Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

2.1K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
2.1K
Personal Protective Equipment01:20

Personal Protective Equipment

2.5K
Personal protective equipment (PPE) is unique clothing or equipment worn by an employee to minimize or prevent exposure to infectious agents. PPE creates a barrier between the employee and the infectious materials. PPE must be readily available in the patient care area. PPE includes gloves, gowns and aprons, masks and respirators, goggles, face shields, shoes, and headcovers:
2.5K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

730
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
730
Transmission-based Precautions I: Contact, Enteric, and Droplets01:17

Transmission-based Precautions I: Contact, Enteric, and Droplets

5.0K
Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
5.0K
Vaccinations01:51

Vaccinations

53.2K
Overview
53.2K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

3.9K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Communication skills - breaking bad news.

Indian pediatrics·2008
Same author

Communication skills--talking to parents.

Indian pediatrics·2008
Same author

Choosing antibiotics for community acquired pneumonia.

Indian pediatrics·2003
Same author

Asthma and the school going child.

Indian pediatrics·2002
Same journal

Erratum: A Prospective Study on the Effect of Antiseizure Medications on the Bone Mineral Density of Children with Drug-Naïve Epilepsy.

Indian pediatrics·2026
Same journal

Adding Purpose to Pulse: 2025 Pediatric Life Support Update.

Indian pediatrics·2026
Same journal

PEX6-Associated Heimler Syndrome 2 Presenting with Bernard-Soulier Syndrome.

Indian pediatrics·2026
Same journal

HLA Typing in Pediatric Celiac Disease: From Genetic Association to Clinical Application.

Indian pediatrics·2026
Same journal

Microbial Conversations Between the Gut and Urinary Tract: Emerging Implications for Kidney and Urinary Tract Diseases.

Indian pediatrics·2026
Same journal

Prevalence and Associated Social Factors of Prediabetes in Children and Adolescents in India: A Systematic Review and Meta-Analysis.

Indian pediatrics·2026
See all related articles

Related Experiment Video

Updated: Mar 15, 2026

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

11.4K

Protection Against Pertussis.

Parang N Mehta1

  • 1Department of Pediatrics, Mehta Hospital, Surat, Gujarat, India. Correspondence to: Dr Parang N Mehta, Consultant Pediatrician, Mehta Hospital, Opposite Putli, Sagrampura, Surat 395 002, India. parang@mehtachildcare.com.

Indian Pediatrics
|August 29, 2016
PubMed
Summary
This summary is machine-generated.

Pertussis (whooping cough) remains a global concern despite decades of vaccination. New strategies are urgently needed to protect infants and address outbreaks in vaccinated populations.

More Related Videos

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
16:56

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Published on: August 30, 2014

17.7K
Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
06:32

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Published on: September 19, 2016

11.2K

Related Experiment Videos

Last Updated: Mar 15, 2026

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

11.4K
Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
16:56

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Published on: August 30, 2014

17.7K
Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
06:32

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Published on: September 19, 2016

11.2K

Area of Science:

  • Immunology
  • Public Health
  • Infectious Diseases

Background:

  • Pertussis (whooping cough) persists globally despite extensive vaccination efforts.
  • Outbreaks occur even in areas with high immunization rates, highlighting vaccine limitations.
  • Focus on vaccine type debates overshadows critical issues like infant mortality and persistent outbreaks.

Purpose of the Study:

  • To address the ongoing challenge of pertussis control worldwide.
  • To highlight the urgent need for strategies protecting vulnerable infants.
  • To emphasize the concern over pertussis outbreaks in highly vaccinated populations.

Main Methods:

  • This study is a review and analysis of existing pertussis epidemiology and control strategies.
  • It examines the limitations of current vaccines and discusses the implications of outbreaks.
  • It considers the development of new vaccines and their accessibility in resource-poor settings.

Main Results:

  • Current pertussis vaccines have not eradicated or fully controlled the disease.
  • Significant disease burden and mortality persist, particularly in young infants.
  • Repeated outbreaks occur even in populations with high vaccine coverage.

Conclusions:

  • Effective pertussis control requires strategies beyond the current vaccine debate.
  • Protecting the most vulnerable populations, especially infants, is a critical priority.
  • Cost-effective strategies and accessible new vaccines are essential for global pertussis management.